Our site will be undergoing maintenance Saturday June 3 (midnight) through Sunday June 4 (noon). During that time, our login will not be available. Thank you for your patience.
This supplement to the Clinical Journal of Oncology Nursing contains the first comprehensive guidelines for managing side effects from lenalidomide, thalidomide, and bortezomib used in the treatment of multiple myeloma.